Literature DB >> 19471256

Distribution and manifestations of inflammatory bowel disease in Asians, Hispanics, and African Americans: a systematic review.

Jason K Hou1, Hashem El-Serag, Selvi Thirumurthi.   

Abstract

OBJECTIVES: Although inflammatory bowel disease (IBD) has been reported worldwide, most studies have focused on Caucasian populations. Our aim was to summarize the existing epidemiological literature, identify temporal trends, and highlight areas for future research.
METHODS: We carried out a systematic review following standard guidelines to evaluate the incidence, prevalence, temporal trends, disease characteristics, and extra-intestinal manifestations (EIMs) of IBD in African American, Hispanic, and Asian adult patients. Two investigators independently identified eligible studies through 2008 using structured keyword searches in PubMed, applied several inclusion and exclusion criteria, and abstracted the data.
RESULTS: Twenty-eight publications were included, encompassing 1,272 Hispanic, 547 African American, and 35,844 Asian patients with IBD. Greater proportions of Hispanic (36.7-84.3%) and Asian (30.6-74.7%) patients were diagnosed with ulcerative colitis (UC) than with Crohn's disease (CD) compared with African Americans (27.6-40.6%). The prevalence rates of IBD in Hispanics in Puerto Rico varied between 5 (rural) and 62 (urban) per 100,000. Crude prevalence rates in Asia varied between 6 (Singapore) and 136 (South Asians in UK) per 100,000 for UC, and between 3 (Singapore) and 33 (South Asians in UK) per 100,000 for CD. Three studies reported a rising annual incidence rate among Hispanics (from 2.6 to 7.5 per 100,000) and Asians (from 0.22 to 3.62 per 100,000). Fistulizing CD was reported in nearly one-third of Hispanic patients, up to one-quarter of African-American patients, and up to one-half of Asian patients. Ileocolonic disease was the most common site of CD among the three racial/ethnic groups, with skin and joint manifestations noted as the most common EIMs.
CONCLUSIONS: Prevalence and incidence rates in Hispanics and Asians have recently increased. There are many similarities and differences in disease location and behavior among racial/ethnic groups. There is a paucity of literature on all aspects of the disease in Hispanics, in the incidence and prevalence of IBD in African Americans, and in Asians with IBD outside Asia.

Entities:  

Mesh:

Year:  2009        PMID: 19471256     DOI: 10.1038/ajg.2009.190

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  66 in total

1.  Temporal genomewide expression profiling of DSS colitis reveals novel inflammatory and angiogenesis genes similar to ulcerative colitis.

Authors:  Kai Fang; Megan Bruce; Christopher B Pattillo; Songlin Zhang; Randolph Stone; John Clifford; Christopher G Kevil
Journal:  Physiol Genomics       Date:  2010-10-05       Impact factor: 3.107

Review 2.  The global burden of IBD: from 2015 to 2025.

Authors:  Gilaad G Kaplan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-09-01       Impact factor: 46.802

Review 3.  Regulation of the immune system by biodiversity from the natural environment: an ecosystem service essential to health.

Authors:  Graham A Rook
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-23       Impact factor: 11.205

4.  Racial and ethnic differences in health care utilization and outcomes among ulcerative colitis patients in an integrated health-care organization.

Authors:  Dan Li; Bernadette Collins; Fernando S Velayos; Liyan Liu; James D Lewis; James E Allison; Nicole T Flowers; Susan Hutfless; Oren Abramson; Lisa J Herrinton
Journal:  Dig Dis Sci       Date:  2013-10-31       Impact factor: 3.199

Review 5.  Recent advances in understanding Crohn's disease.

Authors:  Antonio Di Sabatino; Laura Rovedatti; Francesca Vidali; Thomas Thornton Macdonald; Gino Roberto Corazza
Journal:  Intern Emerg Med       Date:  2011-05-08       Impact factor: 3.397

Review 6.  Differentiation of Crohn's disease from intestinal tuberculosis in India in 2010.

Authors:  Anna Benjamin Pulimood; Deepak Narayan Amarapurkar; Ujjala Ghoshal; Mathew Phillip; Cannanore Ganesh Pai; Duvvur Nageshwar Reddy; Birender Nagi; Balakrishna Siddhartha Ramakrishna
Journal:  World J Gastroenterol       Date:  2011-01-28       Impact factor: 5.742

7.  Racial disparities in surgical outcomes of patients with Inflammatory Bowel Disease.

Authors:  Samuel R Montgomery; Paris D Butler; Chris J Wirtalla; Karole T Collier; Rebecca L Hoffman; Cary B Aarons; Scott M Damrauer; Rachel R Kelz
Journal:  Am J Surg       Date:  2018-05-12       Impact factor: 2.565

8.  What can we learn from inflammatory bowel disease in developing countries?

Authors:  Sunny H Wong; Siew C Ng
Journal:  Curr Gastroenterol Rep       Date:  2013-03

9.  Alpha-Linolenic Acid Alleviates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice.

Authors:  Jeongtae Kim; Meejung Ahn; Yuna Choi; Taeyoung Kang; Jungeun Kim; Nam Ho Lee; Gi Ok Kim; Taekyun Shin
Journal:  Inflammation       Date:  2020-10       Impact factor: 4.092

10.  Race/Ethnicity-Specific Disparities in the Severity of Disease at Presentation in Adults with Ulcerative Colitis: A Cross-Sectional Study.

Authors:  Garland Castaneda; Benny Liu; Sharon Torres; Taft Bhuket; Robert J Wong
Journal:  Dig Dis Sci       Date:  2017-08-30       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.